Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$25.02 - $54.99 $3.86 Million - $8.48 Million
-154,160 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$36.42 - $57.0 $1.22 Million - $1.91 Million
33,500 Added 27.76%
154,160 $6.36 Million
Q1 2020

May 15, 2020

BUY
$31.65 - $46.87 $1.54 Million - $2.28 Million
48,560 Added 67.35%
120,660 $5.1 Million
Q4 2019

Feb 14, 2020

SELL
$36.21 - $51.4 $1.23 Million - $1.74 Million
-33,900 Reduced 31.98%
72,100 $3.08 Million
Q3 2019

Nov 14, 2019

SELL
$22.22 - $44.01 $4.32 Million - $8.55 Million
-194,300 Reduced 64.7%
106,000 $3.82 Million
Q2 2019

Aug 14, 2019

SELL
$23.32 - $28.12 $1.91 Million - $2.3 Million
-81,700 Reduced 21.39%
300,300 $8.03 Million
Q1 2019

May 13, 2019

SELL
$16.17 - $27.38 $485,100 - $821,400
-30,000 Reduced 7.28%
382,000 $10.3 Million
Q4 2018

Feb 14, 2019

BUY
$14.32 - $22.92 $28,640 - $45,840
2,000 Added 0.49%
412,000 $6.66 Million
Q3 2018

Nov 14, 2018

BUY
$13.03 - $21.81 $528,340 - $884,351
40,548 Added 10.98%
410,000 $8.51 Million
Q2 2018

Aug 14, 2018

BUY
$15.07 - $22.34 $443,841 - $657,957
29,452 Added 8.66%
369,452 $5.64 Million
Q4 2017

Feb 14, 2018

SELL
$26.84 - $39.14 $3.36 Million - $4.89 Million
-125,000 Reduced 26.88%
340,000 $10.2 Million
Q3 2017

Nov 13, 2017

BUY
$29.49 - $38.37 $13.7 Million - $17.8 Million
465,000
465,000 $17.5 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.24B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.